comparing glp-1 agonists The New Weight Management Meds Comparative features of glucagon-like peptide
Description
2020, doi: 10.1038/s41467-020-17556-z
Understanding GLP-1s roles potentially prevent and manage obesity, T2D, and some forms of cancer
Wu et al
At Rivas, when a patient plateaus, our providers always ask why: Is there dose headroom we haven't used yet
PMID: 8216285
GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure
